Will Emicizumab be the support for surgeons in acquired haemophilia?

Life-threatening bleeding during surgery is always a problem for the surgeon. In this paper, we have highlighted the problem of insufficient diagnosis of acquired haemophilia, as issues omitted by non-haematologists. Based on a clinical case and available literature, we presented the problem of acquired haemophilia and the latest methods for its treatment. Haemophilia is a problem for non-haematologist professionals. It is important to note that prolonged bleeding may be its symptom. There is now a new antibody emicizumab that has the potential to become an important aid in the work of surgeons.